Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Hims & Hers Health ( (HIMS) ) has issued an announcement.
Hims & Hers Health, Inc. has announced that it will disseminate information about its operations, products, and services through various public channels, including its websites, social media accounts, and press releases. This approach aims to ensure broad and inclusive distribution of material information to the public, potentially impacting how stakeholders access updates about the company’s activities.
The most recent analyst rating on (HIMS) stock is a Sell with a $30.00 price target. To see the full list of analyst forecasts on Hims & Hers Health stock, see the HIMS Stock Forecast page.
Spark’s Take on HIMS Stock
According to Spark, TipRanks’ AI Analyst, HIMS is a Neutral.
Hims & Hers Health’s overall score is driven by strong financial performance and positive earnings call sentiment, indicating growth potential. However, high leverage, cash flow concerns, and a high P/E ratio suggest caution. The company’s strategic expansions and technological advancements are promising, but operational challenges and valuation concerns temper the outlook.
To see Spark’s full report on HIMS stock, click here.
More about Hims & Hers Health
Hims & Hers Health, Inc. operates in the telehealth industry, providing a range of health and wellness products and services through its online platform. The company focuses on offering accessible and affordable healthcare solutions, targeting a broad market with its digital health services.
Average Trading Volume: 35,560,844
Technical Sentiment Signal: Buy
Current Market Cap: $13.07B
For an in-depth examination of HIMS stock, go to TipRanks’ Overview page.